News und Analysen

The pharmaceutical sector is famously volatile, usually driven by the binary outcomes of clinical trials. A drug either works, sending the stock to the moon, or it fails, causing a crash

After months of frustration and sideways trading, investors in Baidu (NASDAQ: BIDU) finally have a tangible reason to be optimistic. Over the last few weeks, the stock has risen approximately 15%

The energy demands of the digital age are no longer just talking points in quarterly earnings calls. For the past two years, tech sector giants have warned that the rapid expansion of artificial

Will they or won’t they? Stocks have moved higher in the last quarter of 2025 as the Federal Reserve started to cut interest rates. However, investors are wondering what’s next. There are

If you’re checking your portfolio at the end of December and you’re invested in advanced nuclear, the view can look ugly. The industry, a darling of the 2025 market, is currently flashing red

Mining stocks enjoyed major tailwinds in 2025, a consequence of record years for gold and silver, a near-record year for palladium, and increasing demand for lithium.  

But as much as gold and

For the last two years, the stock market has been obsessed with hardware. Investors poured trillions of dollars into the companies building the chips, data centers, and infrastructure required to

Income investors have been on a bumpy ride since mid-2024. Since then, the Federal Reserve has cut interest rates six times, including a 25-basis point cut at the Dec. 10, 2025 meeting. 

In turn